Product Information
VERAPAMIL ER 180 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.1914 per EA under NDC 75834015805. Its NADAC has been published 242 times since Dec 8, 2021.
FDA first approved this application on May 5, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
180 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834015805
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206173FDA Approved
5/5/2017
TE Code
AB
On Market Since
5/15/2019
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL ER 180 MG TABLET has been published 242 times since Dec 8, 2021, and over the history we have for it it has declined 8.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1914 per EA |
|---|---|
| All-time high | $0.2091 (Dec 15, 2021) |
| All-time low | $0.1572 (Nov 20, 2024) |
| 52-week high | $0.1940 |
| 52-week low | $0.1781 |
| Median price | $0.1896 |
| Average price | $0.1876 |
| Largest weekly change | -17.6% (Nov 20, 2024) |
| Weeks tracked | 242 |
| Tracking since | Dec 8, 2021 |
1W
N/A
1M
N/A
3M
-0.9%
6M
-0.8%
1Y
+6.5%
3Y
+4.7%
5Y
N/A
All
-8.5%
Last surveyed Jul 22, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VERAPAMIL ER 180 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL ER 180 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.1914 per EA (NDC 75834015805), effective Jul 22, 2026.
How has the price of VERAPAMIL ER 180 MG TABLET changed over time?
Over the history we have for it, the NADAC for VERAPAMIL ER 180 MG TABLET has declined 8.5%. It has been tracked across 242 weekly CMS publications since Dec 8, 2021.
What are the highest and lowest recorded NADAC prices for VERAPAMIL ER 180 MG TABLET?
Since Dec 8, 2021, the NADAC for VERAPAMIL ER 180 MG TABLET has ranged from a low of $0.1572 (Nov 20, 2024) to a high of $0.2091 (Dec 15, 2021), with a median of $0.1896 per EA.
Are there cheaper alternatives to VERAPAMIL ER 180 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VERAPAMIL ER 180 MG TABLET, is $0.1911 per EA — about 0% below VERAPAMIL ER 180 MG TABLET.
Who manufactures VERAPAMIL ER 180 MG TABLET?
VERAPAMIL ER 180 MG TABLET (NDC 75834015805) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.